No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Devices
Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China. It offers blood glucose and pressure monitors; point of care testing products; digital management tool solutions; non-invasive screening products; and PTS and Trividia products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products. The company was founded in 2002 and is based in Changsha, the People’s Republic of China.
www.sinocare.comNo one on the platform currently holds 300298.SZ.
No tracked institution reports a position in 300298.SZ as of their last filing.
No one on the platform has traded 300298.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 1.5% | 7.2% | 9.9% | — | — | — |
| Rev. Growth % | 4.9% | 18.2% | ||||
| Profit Margin % | 2.0% | 6.4% | 11.5% | |||
| Free Cash Flow Margin % | 8.7% | 7.1% | 9.0% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $5.0B | +5.2% | $0.71 | $0.68–$0.74 | — | 2 |
| 2027 | $5.5B | +9.6% | $0.85 | $0.81–$0.89 | — | 2 |
| 2028 | $6.1B | +9.6% | $0.96 | $0.95–$0.98 | — | 2 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 0 of the last 3 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-04 | $0.28 | $0.23 | -17.9% |
| 2026-04-28 | $0.22 | $0.18 | -18.2% |
| 2026-04-27 | $0.20 | $-0.22 | -210.0% |
| $8.17 |
| -1.33% |
| $6.2B |
| — |
| 600587.SSShinva Medical Instrument Co., Ltd. | $12.23 | -1.05% | $7.4B | — |
| 688016.SSShanghai MicroPort Endovascular MedTech Co., Ltd. | $83.35 | +0.07% | $10.1B | — |
Source: Financial Modeling Prep · peers by sector/industry